INM
INM
NASDAQ · Pharmaceuticals

Inmed Pharmaceuticals Inc

$1.55
+0.05 (+3.33%)
As of Jun 24, 10:18 PM ET ·
Analyst Consensus
Strong Sell
8
Analysts
Moderate
Coverage
Buy 0 0%
Hold 3 38%
Sell 5 63%
Price Target
Analyst Price Target +2,071.0% upside
Low Target $24.21
Average Target $33.65
High Target $46.15
Current Price $1.55
Current
$1.55
Target
$33.65
$24.21 $33.65 avg $46.15
Scenario Analysis
Bear Case
$24.21
1,461.9%
Low target
Base Case
$33.65
+2,071.0%
Avg target
Bull Case
$46.15
+2,877.4%
High target
Risk/Reward
2.0x
Balanced
Price in Context
52-Week High
$5.50
-71.8% from high
52-Week Low
$0.58
+169.6% from low
Target vs 52W High
$33.65
+511.8% vs high
Peer Consensus — Pharmaceuticals
Stock Consensus Analysts Buy % Target Upside
LLY
Eli Lilly and Co.
Strong Buy 39 79% $1,330.33 +19.1%
RDY
Dr. Reddy's Laboratories
Sell 44 50% +0.0%
JNJ
Johnson & Johnson
Buy 31 68% $299.55 +24.3%
MRK
Merck & Co. Inc.
Buy 36 69% $159.27 +32.1%
PFE
Pfizer Inc.
Hold 36 42% $33.90 +41.0%
BMY
Bristol-Myers Squibb Co
Hold 36 39% $174.50 +217.3%
ZTS
Zoetis Inc
Buy 24 58% $209.87 +168.5%
RPRX
Royalty Pharma Plc- Cl A
Strong Buy 16 88% $36.26 -33.2%